Literature DB >> 9162437

Obesity and the sympathetic nervous system.

G Grassi1, B M Cattaneo, G Seravalle, M Colombo, F Cavagnini, G Mancia.   

Abstract

Several epidemiological studies have shown that obesity represents an independent risk factor for development of cardiovascular diseases, including hypertension, myocardial ischaemia, and cardiac arrhythmias. Although the metabolic and the haemodynamic alterations occurring in the obese state have been well defined for several years, our knowledge on the sympathetic alterations occurring in this condition is more scarce and controversial. This paper reviews the evidence that human obesity is characterized by abnormalities in sympathetic cardiovascular control, in the light of the results of recent studies performed by employing a sensitive technique to assess sympathetic activity in humans, i.e. microneurography. Evidence is provided that sympathetic overactivity is a common hallmark of the obese state, even when blood pressure levels are within the normal range. It will also discuss the potential mechanisms responsible for this sympathetic activation, suggesting that overweight-related metabolic alterations, such as the insulin resistance state, and abnormalities in sympathetic cardiovascular control exerted by arterial baroreceptors may play a pathogenetic role. Finally, the effects of body weight reduction on the sympathetic overactivity which characterizes the obese state will also be examined.

Entities:  

Mesh:

Year:  1996        PMID: 9162437

Source DB:  PubMed          Journal:  Blood Press Suppl        ISSN: 0803-8023


  9 in total

1.  Morbidly obese patients are hemodynamically stable during laparoscopic surgery: a thoracic bioimpedance study.

Authors:  Yoela Aloni; Shmuel Evron; Tiberiu Ezri; Benjamin Medalion; Michael Protianov; Peter Szmuk; Reuven Zimlichman; Michael Muggia-Sullam
Journal:  J Clin Monit Comput       Date:  2006-06-21       Impact factor: 2.502

2.  Abnormal sympathetic reactivity to the cold pressor test in overweight humans.

Authors:  Jeanie Park; Holly R Middlekauff; Vito M Campese
Journal:  Am J Hypertens       Date:  2012-08-16       Impact factor: 2.689

3.  Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy.

Authors:  Yong Wang; Jingang Liu
Journal:  Obes Surg       Date:  2008-10-08       Impact factor: 4.129

4.  Elevated resting heart rate and reduced orthostatic tolerance in obese humans.

Authors:  Joshua F Lee; Michelle L Harrison; Kevin M Christmas; Kiyoung Kim; Chansol Hurr; R Matthew Brothers
Journal:  Clin Auton Res       Date:  2013-11-29       Impact factor: 4.435

5.  P-wave duration and dispersion in obese subjects.

Authors:  Feridun Kosar; Yüksel Aksoy; Fahri Ari; Lezzan Keskin; Ibrahim Sahin
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-01       Impact factor: 1.468

Review 6.  Central sympathetic overactivity: maladies and mechanisms.

Authors:  James P Fisher; Colin N Young; Paul J Fadel
Journal:  Auton Neurosci       Date:  2009-03-06       Impact factor: 3.145

Review 7.  Optimizing blood pressure control in the obese patient.

Authors:  Tobias Pischon; Arya M Sharma
Journal:  Curr Hypertens Rep       Date:  2002-10       Impact factor: 5.369

8.  Blood Pressure Control at Rest and during Exercise in Obese Children and Adults.

Authors:  Konstantina Dipla; George P Nassis; Ioannis S Vrabas
Journal:  J Obes       Date:  2012-05-14

Review 9.  Obesity and hypertensive heart disease: focus on body composition and sex differences.

Authors:  Giovanni de Simone; Costantino Mancusi; Raffaele Izzo; Maria Angela Losi; L Aldo Ferrara
Journal:  Diabetol Metab Syndr       Date:  2016-11-30       Impact factor: 3.320

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.